INFI - Infinity Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

INFI is currently covered by 3 analysts with an average price target of $2.89. This is a potential upside of $2.89 (0%) from yesterday's end of day stock price of $0.

Infinity Pharmaceuticals's activity chart (see below) currently has 24 price targets and 22 ratings on display. The stock rating distribution of INFI is 60% BUY and 40% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.17% with an average time for these price targets to be met of 61.5 days.

Highest price target for INFI is $1, Lowest price target is $1, average price target is $2.89.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 24-Feb-2023. First documented stock forecast 15-Jun-2016.

Currently out of the existing stock ratings of INFI, 3 are a BUY (60%), 2 are a HOLD (40%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

3

1 years 1 months 26 days ago

0/4 (0%)

$2.38 (383.87%)

Hold

1.5

$1.5 (0.00%)

3

1 years 5 months 3 days ago

0/6 (0%)

$0.85 (130.77%)

Buy

12

1 years 8 months 7 days ago

0/1 (0%)

$8.8 (275.00%)

Buy

4

$4 (0.00%)

12

2 years 19 days ago

0/3 (0%)

$2.86 (250.88%)

Hold

6

$5.98 (29900.00%)

2 years 8 months 18 days ago

0/1 (0%)

$3.07 (104.78%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INFI (Infinity Pharmaceuticals) average time for price targets to be met?

On average it took 61.5 days on average for the stock forecasts to be realized with a an average price target met ratio 29.17

Which analyst has the current highest performing score on INFI (Infinity Pharmaceuticals) with a proven track record?

ANDREW D'SILVA

Which analyst has the current lower performing score on INFI (Infinity Pharmaceuticals) with a proven track record?

ROBYN KARNAUSKAS

Which analyst has the most public recommendations on INFI (Infinity Pharmaceuticals)?

Andrew D'silva has 6 price targets and 5 ratings on INFI

Which analyst is the currently most bullish on INFI (Infinity Pharmaceuticals)?

Kevin Degeeter with highest potential upside - $8.98

Which analyst is the currently most reserved on INFI (Infinity Pharmaceuticals)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?